doi:10.1007/s12250-021-00369-9

[1]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
[2]
Ren-rong TIAN, Qing-jiao LIAO, Xulin CHEN, 2008: Prevention and Treatment of KSHV-associated Diseases with Antiviral Drugs, Virologica Sinica, 23, 486-495. doi: 10.1007/s12250-008-2995-y
[3]
Chao Shan, Xiaodan Li, Chenglin Deng, Baodi Shang, Linlin Xu, Hanqing Ye, Zhiming Yuan, Bo Zhang, 2013: Development and Characterization of West Nile Virus Replicon Expressing Secreted Gaussia Luciferase, Virologica Sinica, 28, 161-166. doi: 10.1007/s12250-013-3332-7
[4]
Min Wang, Jingjing Yan, Liuyao Zhu, Meng Wang, Lizhen Liu, Rui Yu, Ming Chen, Jingna Xun, Yuling Zhang, Zhigang Yi, Shuye Zhang, 2020: The Establishment of Infectious Clone and Single Round Infectious Particles for Coxsackievirus A10, Virologica Sinica, 35, 426-435. doi: 10.1007/s12250-020-00198-2
[5]
Leike Zhang, Jia Liu, Ruiyuan Cao, Mingyue Xu, Yan Wu, Weijuan Shang, Xi Wang, Huanyu Zhang, Xiaming Jiang, Yuan Sun, Hengrui Hu, Yufeng Li, Gang Zou, Min Zhang, Lei Zhao, Wei Li, Xiaojia Guo, Xiaomei Zhuang, Xing-Lou Yang, Zheng-Li Shi, Fei Deng, Zhihong Hu, Gengfu Xiao, Manli Wang, Wu Zhong, 2020: Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro, Virologica Sinica, 35, 776-784. doi: 10.1007/s12250-020-00288-1
[6]
Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 0: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica. doi: 10.1016/j.virs.2022.01.029
[7]
Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6
[8]
Chunchen Wu, Wenzhong Yang, Xiaoxue Wu, Tianzhu Zhang, Yaoyao Zhao, Wei Ren, Jianbo Xia, 2020: Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women, Virologica Sinica, 35, 305-310. doi: 10.1007/s12250-020-00227-0
[9]
Yi Yan, Ke Wu, Jun Chen, Haizhou Liu, Yi Huang, Yong Zhang, Jin Xiong, Weipeng Quan, Xin Wu, Yu Liang, Kunlun He, Zhilong Jia, Depeng Wang, Di Liu, Hongping Wei, Jianjun Chen, 2021: Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing, Virologica Sinica, 36, 901-912. doi: 10.1007/s12250-021-00378-8
[10]
Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008
[11]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[12]
Pingping Yao, Yachun Zhang, Yisheng Sun, Yulin Gu, Fang Xu, Bo Su, Chen Chen, Hangjing Lu, Dehui Wang, Zhangnv Yang, Biao Niu, Jiancai Chen, Lixia Xie, Lei Chen, Yajing Zhang, Hui Wang, Yuying Zhao, Yue Guo, Juncheng Ruan, Zhiyong Zhu, Zhenfang Fu, Dayong Tian, Qi An, Jianmin Jiang, Hanping Zhu, 2020: Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell, Virologica Sinica, 35, 348-350. doi: 10.1007/s12250-020-00241-2
[13]
Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8
[14]
Yafei Zhang, Changtai Wang, Mingfeng Han, Jun Ye, Yong Gao, Zhongping Liu, Tengfei He, Tuantuan Li, Mengyuan Xu, Luping Zhou, Guizhou Zou, Mengji Lu, Zhenhua Zhang, 2020: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference, Virologica Sinica, 35, 758-767. doi: 10.1007/s12250-020-00273-8
[15]
Yang Li, Hao-Rui Si, Yan Zhu, Nan Xie, Bei Li, Xiang-Ping Zhang, Jun-Feng Han, Hong-Hong Bao, Yong Yang, Kai Zhao, Zi-Yuan Hou, Si-Jia Cheng, Shuan-Hu Zhang, Zheng-Li Shi, Peng Zhou, 0: Characteristics of SARS-CoV-2 transmission in a medium-sized city with traditional communities during the early COVID-19 epidemic in China, Virologica Sinica. doi: 10.1016/j.virs.2022.01.030
[16]
Hang Yang, Huijun Yuan, Xiaohui Zhao, Meng Xun, Shangrui Guo, Nan Wang, Bing Liu, Hongliang Wang, 0: Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells, Virologica Sinica. doi: 10.1016/j.virs.2022.03.003
[17]
Dao-min ZHUANG, Jing-yun LI, 2010: A Few Specialized Issues That Should Be Focused on Anti-HIV Drug Evaluation In Vitro^*, Virologica Sinica, 25, 301-306. doi: 10.1007/s12250-010-3139-8
[18]
Alfred Niyokwishimira, Yongxi Dou, Bang Qian, Prajapati Meera, Zhidong Zhang, 2018: Reverse Genetics for Peste des Petits Ruminants Virus: Current Status and Lessons to Learn from Other Non-segmented Negative-Sense RNA Viruses, Virologica Sinica, 33, 472-483. doi: 10.1007/s12250-018-0066-6
[19]
卢建红, 邵卫星, 龙进学, 刘玉良, 石火英, 刘秀梵*, 2005: Construction and Confirmation of Plasmids Transcripting and Expressing Genes from Avian Influenza Virus H9N2 Subtype, Virologica Sinica, 20, 388-392.
[20]
Carla Bianca Luena Victorio, Yishi Xu, Qimei Ng, Vincent T. K. Chow, Kaw Bing Chua, 2020: Reverse Genetic Analysis of Adaptive Mutations within the Capsid Proteins of Enterovirus 71 (EV-A71) Strains Necessary for Infection of CHO-K1 Cells, Virologica Sinica, 35, 110-114. doi: 10.1007/s12250-019-00167-4